{"id":"NCT01589523","sponsor":"Children's Hospital Medical Center, Cincinnati","briefTitle":"GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis","officialTitle":"Conjugated Cholic Acid for the Treatment of Inborn Errors in Bile Acid Synthesis Involving Side-Chain Conjugation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2019-01-22","completion":"2019-01-22","firstPosted":"2012-05-02","resultsPosted":"2022-05-12","lastUpdate":"2022-06-08"},"enrollment":5,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bile Acid Synthesis Defect","Inborn Error of Bile Acid Metabolism","Inborn Error of Bile Acid Conjugation"],"interventions":[{"type":"DRUG","name":"Glycocholic Acid","otherNames":["Conjugated Cholic Acid"]}],"arms":[{"label":"GlycoCholic Acid, Study Drug","type":"EXPERIMENTAL"}],"summary":"The purpose of this research study is to determine the way (mechanisms) by which your defect in bile acid handling (metabolism) causes your liver disease or abnormality in absorption of vitamins and the effect of an investigational bile acid therapy (glycocholic acid) on your vitamin absorption and your liver disease. An investigational therapy is one that not approved by the United States Food and Drug Administration (FDA) and is being provided to you under an Investigational New Drug application from the FDA.","primaryOutcome":{"measure":"Conjugated Cholic Acid (GCA) for the Treatment of Inborn Errors in Bile Acid Synthesis Involving Side-chain Conjugation.","timeFrame":"Up to 10 years","effectByArm":[{"arm":"15 mg/Kg Body Weight/Day","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Week","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["23415802","25163551"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":5},"commonTop":[]}}